Childhood and adolescent cancer statistics, 2014
2014/01/31 by Elizabeth Ward, Carol DeSantis, Anthony Robbins +2 · 2,437 citations
Medicine · #Acute Lymphoblastic Leukemia research #Cancer #Childhood Cancer Survivors' Quality of Life #Childhood cancer #Congenital Diaphragmatic Hernia Studies #Demography #Disease #Environmental health #Gerontology #Incidence (geometry) #Internal medicine #Medicine #Pediatric cancer #Pediatrics #Population
paper · pdf · doi:10.3322/caac.21219
published in CA A Cancer Journal for Clinicians 64(2), 83-103 (Wiley)
openalex publication_date 2014/01/31 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01
Abstract
In this article, the American Cancer Society provides estimates of the number of new cancer cases and deaths for children and adolescents in the United States and summarizes the most recent and comprehensive data on cancer incidence, mortality, and survival from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries (which are reported in detail for the first time here and include high-quality data from 45 states and the District of Columbia, covering 90% of the US population). In 2014, an estimated 15,780 new cases of cancer will be diagnosed and 1960 deaths from cancer will occur among children and adolescents aged birth to 19 years. The annual incidence rate of cancer in children and adolescents is 186.6 per 1 million children aged birth to 19 years. Approximately 1 in 285 children will be diagnosed with cancer before age 20 years, and approximately 1 in 530 young adults between the ages of 20 and 39 years is a childhood cancer survivor. It is therefore likely that most pediatric and primary care practices will be involved in the diagnosis, treatment, and follow-up of young patients and survivors. In addition to cancer statistics, this article will provide an overview of risk factors, symptoms, treatment, and long-term and late effects for common pediatric cancers.
Citations
Cited by
- Arterial Spin Labeling to Predict Brain Tumor Grading in Children: Correlations between Histopathologic Vascular Density and Perfusion MR Imaging
- Life Expectancy of Adult Survivors of Childhood Cancer Over 3 Decades
- Pediatric CNS Radiation Oncology: Recent Developments and Novel Techniques
- RET , NTRK , ALK , BRAF , and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas
- Pediatric lymphoma may develop by "one-step" cell transformation of a lymphoid cell
- Using functional near-infrared spectroscopy to study neurocognitive function in adult survivors of childhood acute lymphoblastic leukemia, an exploratory study
- Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival
- Diagnostic performance of F-18 FDG PET/CT in the detection of bone marrow involvement in paediatric hodgkin lymphoma: A meta-analysis
- In vitro models of medulloblastoma: Choosing the right tool for the job
- Current Status and Future Perspective on Molecular Imaging and Treatment of Neuroblastoma
- Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review. [europepmc]
- Cancer incidence rates and trends among children and adolescents in the United States, 2001-2009. [europepmc]
- Biology of childhood acute lymphoblastic leukemia. [europepmc]
- Recent advances of cocktail chemotherapy by combination drug delivery systems. [europepmc]
- Association of body mass index and survival in pediatric leukemia: a meta-analysis. [europepmc]
- Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia. [europepmc]
- In Vitro and in Vivo Mechanism of Bone Tumor Inhibition by Selenium-Doped Bone Mineral Nanoparticles. [europepmc]
- Pediatric Exposures to Ionizing Radiation: Carcinogenic Considerations. [europepmc]
- Estimates of Cancer Incidence in Ethiopia in 2015 Using Population-Based Registry Data. [europepmc]
- Testicular endothelial cells are a critical population in the germline stem cell niche. [europepmc]
- Deep Learning-Based Multi-Omics Data Integration Reveals Two Prognostic Subtypes in High-Risk Neuroblastoma. [europepmc]
- The Major Causes of Death in Children and Adolescents in the United States. [europepmc]
- Digital Health Interventions for Adolescent and Young Adult Cancer Survivors. [europepmc]
- Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia. [europepmc]
- Epidemiology and Etiology of Leukemia and Lymphoma. [europepmc]
- Adult Stem Cells for Bone Regeneration and Repair. [europepmc]
- Life Expectancy of Adult Survivors of Childhood Cancer Over 3 Decades. [europepmc]
- Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance. [europepmc]
- Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. [europepmc]
- Pediatric cancer mortality and survival in the United States, 2001-2016. [europepmc]
- Neuroblastoma. [europepmc]
- The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies. [europepmc]
- CAR T-Cell Therapy in Hematological Malignancies. [europepmc]
- Chemotherapy Side-Effects: Not All DNA Damage Is Equal. [europepmc]
- Physical activity, exercise, and chronic diseases: A brief review. [europepmc]
Related